Retaglutide is a innovative GLP-1 receptor agonist currently under study for the management of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://jayamlya536943.izrablog.com/39388507/semaglutide-a-potential-solution-for-obesity